Nanion US User Meeting (Date to be confirmed)

//Nanion US User Meeting (Date to be confirmed)
Loading Events

Metrion Biosciences look forward to attending and speaking at the Nanion US User Meeting to be held in June 2020.

Metrion’s Chief Scientific Officer Dr Marc Rogers will be presenting on  ‘chronic cardiotoxicity iPSC assays’ at the event, the time and date of the presentation will be confirmed very shortly.

Please email info@metrionbiosciences.com if you wish to arrange a meeting with one of our attendees.

Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs. Our state of the art laboratories at Granta Park house high quality facilities for native and engineered cell line and induced pluripotent stem cell culture, a comprehensive suite of automated patch clamp platforms, multiple manual patch clamp rigs, fluorescence-based screening capability and laboratory data management and reporting systems. Our company is focussed upon delivering a range of high quality ion channel drug discovery services. We provide highly skilled electrophysiology screening services to support client medicinal chemistry optimisation programmes, CiPA compliant cardiac safety profiling assays, neuroscience assays and translational assays. We combine in depth target class knowledge and high quality screening assays with highly experienced and collaborative drug discovery managers to keep your research focused upon meeting both objectives and timelines. Our team has successfully delivered many projects on behalf of our clients from once off screening projects to fully integrated drug discovery programmes delivering clinical candidates.